BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
239 results:

  • 1. Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope.
    Giri S; Sahoo J
    World J Gastroenterol; 2024 Mar; 30(12):1670-1675. PubMed ID: 38617746
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical influence of prophylactic lateral lymph node dissection on oncologic outcomes of patients with mid-low rectal cancer undergoing mesorectal excision: a meta-analysis.
    Ishizuka M; Shibuya N; Hachiya H; Nishi Y; Takayanagi M; Fujita J; Ihara K; Shiraki T; Matsumoto T; Mori S; Iso Y; Nakamura T; Aoki T; Irisawa A
    J Gastrointest Surg; 2024 Apr; 28(4):548-558. PubMed ID: 38583909
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sleep and Risk of pancreatic cancer in the UK Biobank.
    Freeman JR; Saint-Maurice PF; Zhang T; Matthews CE; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):624-627. PubMed ID: 38387085
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epigenetic therapeutic strategies in pancreatic cancer.
    Orlacchio A; Muzyka S; Gonda TA
    Int Rev Cell Mol Biol; 2024; 383():1-40. PubMed ID: 38359967
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibiting autophagy enhanced mitotic catastrophe-mediated anticancer immune responses by regulating the cGAS-STING pathway.
    Bai Z; Peng Y; Xia X; Li Y; Zhong Y; Chen L; Guan Q; Liu W; Zhou Y; Ma L
    Cancer Lett; 2024 Apr; 586():216695. PubMed ID: 38325769
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic pancreatic cancer: A Systematic Review and Meta-Analysis.
    Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
    JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characterization of circulating miRNAs in the treatment of primary liver tumors.
    Umezu T; Tanaka S; Kubo S; Enomoto M; Tamori A; Ochiya T; Taguchi YH; Kuroda M; Murakami Y
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1964. PubMed ID: 38146079
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
    Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
    J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term quality of life is better after laparoscopic compared to open pancreatoduodenectomy.
    Dagorno C; Marique L; Korrel M; de Graaf N; Thouny C; Renault G; Ftériche FS; Aussilhou B; Maire F; Lévy P; Rebours V; Lesurtel M; Sauvanet A; Dokmak S
    Surg Endosc; 2024 Feb; 38(2):769-779. PubMed ID: 38052888
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study.
    Park SM; Kim KB; Han JH; Kim N; Kang TU; Swan H; Kim HJ
    Sci Rep; 2023 Nov; 13(1):18930. PubMed ID: 37919344
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
    Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
    Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Georgakopoulos A
    Hell J Nucl Med; 2023; 26 Suppl():49-51. PubMed ID: 37658564
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story.
    Faggiano A
    J Endocrinol Invest; 2024 Jan; 47(1):35-46. PubMed ID: 37581846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms.
    Mosalem O; Sonbol MB; Halfdanarson TR; Starr JS
    Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101796. PubMed ID: 37414652
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Breakthrough Symptoms Remain an Unmet Need in Symptomatic Patients With Neuroendocrine Tumors and Carcinoid Syndrome.
    Liu E; Hoffman KD; Murfin G; Eccard H
    Pancreas; 2023 Jan; 52(1):e70-e74. PubMed ID: 37378902
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Implications of the interaction between travel burden and area deprivation for patients with pancreatic cancer.
    Murimwa GZ; Meier J; Nehrubabu M; Zeh HJ; Yopp AC; Polanco PM
    Am J Surg; 2023 Oct; 226(4):515-522. PubMed ID: 37355377
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study.
    Su YY; Chao YJ; Wang CJ; Liao TK; Su PJ; Huang CJ; Chiang NJ; Yu YT; Tsai HM; Chen LT; Shan YS
    Int J Surg; 2023 Sep; 109(9):2614-2623. PubMed ID: 37300888
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of COVID-19 lockdowns on postoperative morbidity after hepatectomy: A propensity-score matching study on a national French database.
    Nassar A; Tzedakis S; Marchese U; Dhote A; Dallel MS; Naveendran G; Gaillard M; Coriat R; Marty JR; Fuchs B; Fuks D
    Surgery; 2023 Aug; 174(2):196-202. PubMed ID: 37150714
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.
    Chen K; Yu H; Yang J; Bo Z; Jin C; Wu L; Wang Y; Chen G
    Curr Oncol; 2023 Feb; 30(3):2642-2652. PubMed ID: 36975414
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
    Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
    Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.